BOPI 07 BR/2024 REPERTOIRE NUMERIQUE 15 This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) having the core structure: pharmaceutical compositions containing at least one such modulator, methods of treatment of CFTR mediated diseases, including cystic fibrosis, using such modulators and pharmaceutical compositions, combination pharmaceutical compositions and combination therapies, and processes and intermediates for making such modulators. Compound of Formula I ________________________________________ (11) 21577 Consulter le mémoire (51) H04B 10/2575 (2018.01); H04W 28/08 (2018.01) ; H04W 84/22 (2018.01) (21) 1202300164 - PCT/US2021/055912 (22) 20/10/2021 (30) US n° 63/094,306 du 20/10/2020 (54) Edge Computing Platform Based On Wireless Mesh Architecture. (72) NAIM, Muhammad Ahsan (US) et ROSS, Kevin (US) (73) L3VEL, LLC, 1209 Orange St., Corporation Trust Center, WILMINGTON, Delaware 19801 (US) (74) Cabinet Spoor & Fisher Inc. Ngwafor & Partners, The House of Gideon, Golf/Bastos Quater, Opposite The American Embassy, Entrance-Saint John Paul II Boulevard, P.O. Box 8211, YAOUNDE (CM). (57) Disclosed herein is an architecture for an edge computing platform based on an underlying wireless mesh network. The architecture includes nodes installed with equipment for operating as part of a wireless mesh network, including (1) a first tier of one or more Point of Presence (PoP) node, (2) a second tier of one or more seed nodes that are each directly connected to at least one PoP node via a PoP-to-seed wireless link, and (3) a third tier of one or more anchor nodes that are each connected to at least one seed node either (i) directly via a seed-to-anchor wireless link or (ii) indirectly via one or more intermediate anchor nodes, one or more anchor-to-anchor wireless links, and one seed-to-anchor wireless link, where at least one node in each of these tiers is further installed with equipment for operating as part of an edge computing platform.
RkJQdWJsaXNoZXIy MTM1NDc3MA==